Foghorn Therapeutics Inc.
Biotechnology ResearchView the employees at
Foghorn Therapeutics Inc.-
Caitlin (McMahon) Patriquin Clinical Science at Foghorn Therapeutics
-
Boston, Massachusetts, United States
-
Top 5%
Alexis Khalil, MPH, ELS Senior Director, Medical Writing, at Foghorn Therapeutics-
Top 5%
Sunita Katyal Executive Assistant to Chief Executive Officer | Foghorn Therapeutics Inc.-
Greater Boston
-
Top 5%
Tejal Sharma MS in Project Management| Pharmaceutical Marketing | B.Pharm-
Boston, Massachusetts, United States
-
Rising Star
Eric Humphries Scientist, Medicinal Chemistry-
Camp Warwick, Massachusetts, United States
-
Rising Star
Overview
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
-